Inventor · disambiguated record
Hari Kumar Padmanabhan
Also filed as: PADMANABHAN HARI · PADMANABHAN HARI KUMAR
12 granted patents·16 pending applications·21 citations·filing 2014–2024
85Inventor score
Files withCRISPR THERAPEUTICS AG18VERTEX PHARMA5ACCENTURE GLOBAL SOLUTIONS LTD2DASSAULT SYS SOLIDWORKS CORP2VERTEX PHAMACEUTICALS INCORPORATED1
Top patents by PatentIndex Score
28 records- 0194US11559588B2Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disordersCRISPR THERAPEUTICS AG·Filed 2018·Granted Jan 24, 2023·12 cites·18 claims
- 0286US11459587B2Materials and methods for treatment of pain related disordersVERTEX PHARMA·Filed 2017·Granted Oct 4, 2022·3 cites·17 claims
- 0379US12442020B2Materials and methods for treatment of pain related disordersVERTEX PHARMA·Filed 2022·Granted Oct 14, 2025·0 cites·18 claims
- 0479US11427838B2Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disordersVERTEX PHARMA·Filed 2017·Granted Aug 30, 2022·1 cites·6 claims
- 0576US11174469B2Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disordersCRISPR THERAPEUTICS AG·Filed 2017·Granted Nov 16, 2021·1 cites·11 claims
- 0675US2024318200A1Compositions and methods for gene editingCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 0775US2024066150A1Materials and methods for treatment of pain related disordersVERTEX PHAMACEUTICALS INCORPORATED·Filed 2023·Application pending·0 cites
- 0871US10635461B2Computer-aided interactive learningDASSAULT SYS SOLIDWORKS CORP·Filed 2017·Granted Apr 28, 2020·2 cites·20 claims
- 0970US2023227855A1Materials and Methods for Treatment of Myotonic Dystrophy Type 1 (DM) and Other Related DisordersVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1070US2023330270A1Materials and methods for treatment of friedreich ataxia and other related disordersCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 1169US2022364082A1Compositions and methods for editing the angiopoietin-like 4 (angptl4) geneCRISPR THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 1267US2022340897A1Materials and methods for treatment of apolipoprotein c3 (apociii)-related disordersCRISPR THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 1366US2022290136A1Materials and methods for treatment of amyotrophic lateral sclerosisCRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 1466US2023392134A1Materials and methods for treatment of amyotrophic lateral sclerosisCRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 1562US11263582B2Distributed ledger system for material monitoringACCENTURE GLOBAL SOLUTIONS LTD·Filed 2019·Granted Mar 1, 2022·1 cites·20 claims
- 1660US11920148B2Compositions and methods for gene editingCRISPR THERAPEUTICS AG·Filed 2018·Granted Mar 5, 2024·0 cites·18 claims
- 1759US11801313B2Materials and methods for treatment of pain related disordersVERTEX PHARMA·Filed 2017·Granted Oct 31, 2023·0 cites·10 claims
- 1859US11564997B2Materials and methods for treatment of friedreich ataxia and other related disordersCRISPR THERAPEUTICS AG·Filed 2017·Granted Jan 31, 2023·0 cites·14 claims
- 1955US10055514B2Top-down CAD designDASSAULT SYS SOLIDWORKS CORP·Filed 2014·Granted Aug 21, 2018·1 cites·20 claims
- 2055US2019185849A1Compositions and methods for gene editingCRISPR THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 2152US2020123570A1Materials and methods for treatment of apolipoprotein c3 (apociii)-related disordersCRISPR THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 2246US11407997B2Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disordersCRISPR THERAPEUTICS AG·Filed 2018·Granted Aug 9, 2022·0 cites·15 claims
- 2345US2020248168A1Compositions and methods for treatment of proprotein convertase subtilisin/kexin type 9 (pcsk9)-related disordersCRISPR THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 2444US2020216857A1Materials and methods for treatment of spinocerebellar ataxia type 2 (sca2) and other spinocerebellar ataxia type 2 protein (atxn2) gene related conditions or disordersCRISPR THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 2544US2020095579A1Materials and methods for treatment of merosin-deficient cogenital muscular dystrophy (mdcmd) and other laminin, alpha 2 (lama2) gene related conditions or disordersCRISPR THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 2643US2020040061A1Materials and methods for treatment of early onset parkinson's disease (park1) and other synuclein, alpha (snca) gene related conditions or disordersCRISPR THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 2742US2020090090A1Distributed ledger system for venture managementACCENTURE GLOBAL SOLUTIONS LTD·Filed 2018·Application pending·0 cites
- 2841US2019365929A1Materials and methods for treatment of dystrophic epidermolysis bullosa (deb) and other collagen type vii alpha 1 chain (col7a1) gene related conditions or disordersCRISPR THERAPEUTICS AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hari Kumar Padmanabhan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →